NCT07208227View on ClinicalTrials.gov

In-use Tolerance and Efficacy Study Under Dermatological and Ophthalmological Controls - Face Cream, RV4983A - LA3365

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

February 7, 2022

Study Completion Date

February 7, 2022

Conditions
HealthySensitive SkinDeep Wrinkles
Interventions
OTHER

Face Cream RV4983A LA3365

Cosmetic face cream product applied once a day on face, neck and neckline.

Trial Locations (1)

80288

Eurofins Dermscan Poland Sp. z o. o, Gdansk

All Listed Sponsors
lead

Pierre Fabre Dermo Cosmetique

INDUSTRY

NCT07208227 - In-use Tolerance and Efficacy Study Under Dermatological and Ophthalmological Controls - Face Cream, RV4983A - LA3365 | Biotech Hunter | Biotech Hunter